Abstract
Neurofilaments are a major component of the axonal cytoskeleton and their abnormal accumulation is a prominent feature of the cytopathology encountered in several neurodegenerative diseases1,2,3,4,5,6,7,8. Thus, an attractive and widely held model of pathogenesis involves the participation of disrupted neurofilaments as a common toxic intermediate9,10,11,12,13. Here, in direct contrast to this hypothesis, we show that two neurodegenerative disease models in the mouse, dystonia musculorum (dt)14,15 and a superoxide dismutase 1 (SOD1)-mediated form of human motor neuron disease (amyotrophic lateral sclerosis, ALS)16,17, progress with little or no abatement on a transgenic background in which neurofilaments are withheld from the axonal compartment18. By specifically excluding a necessary role for axonal neurofilaments, our observations redefine the components of the pathogenic pathway leading to axon disruption in these two degenerative diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dickson, D. W. et al. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol. 71, 216–223 (1986).
Goldman, J. E. & Yen, S. H. Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann. Neurol. 19, 209–223 (1987).
Carden, M. J., Lee, V. M.-Y. & Schlaepfer, W. W. 2,5-Hexanedione neuropathy is associated with covalent crosslinking of neurofilament proteins. Neurochem. Pathol. 5, 25–35 (1986).
Eyer, J., McLean, W. G. & Leterrier, J. F. Effect of a single dose of β,β′-Iminodipropionitrile in vivo on the properties of neurofilaments in vitro: comparison with the effect of Imminodipropionitrile added directly to neurofilaments in vitro. J. Neurochem. 52, 1759–1765 (1989).
Pollanen, M. S., Dickson, D. W. & Bergeron, C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52, 183–191 (1993).
Hill, W. D., Lee, V. M.-Y., Hurtig, H., Murray, J. M. & Trojanowski, J. Q. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy body. J. Comp. Neurol. 109, 150–160 (1991).
Griffin, J. W. & Price, D. L. in Experimental and Clinical Neurotoxicology (eds Spencer, P. & Schaumburg, H. H.) 161–178 (Williams and Wilkins, Baltimore, 1980).
Carpenter, S. Proximal axonal enlargement in motor neuron disease. Neurology 18, 841–851 (1968).
Lee, M. K. & Cleveland, D. W. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell Biol. 6, 34–40 (1994).
Coté, F., Collard, J. F. & Julien, J. P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73, 35–46 (1993).
Lee, M. K., Marszalek, J. R. & Cleveland, D. W. Amutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13, 975–988 (1994).
Xu, Z. H., Cork, L. C., Griffin, J. W. & Cleveland, D. W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73, 23–33 (1993).
Cleveland, D. W. et al. Mechanisms of selective motor neurons death in transgenic mouse models of motor neuron disease. Neurology 47, 54–61 (1996).
Yang, Y. et al. An essential cytoskeletal linker protein connecting actin microfilaments ot intermediate filaments. Cell 86, 655–665 (1996).
Brown, A., Bernier, G., Mathieu, M., Rossant, J. & Kothary, R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nature Genet. 10, 301–306 (1995).
Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59–62 (1993).
Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
Eyer, J. & Peterson, A. C. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein. Neuron 12, 389–405 (1994).
Plummer, J., Peterson, A. & Messer, A. Accelerated and widespread neuronal loss occurs in motor neuron degeneration (MND) mice expressing a neurofilament-disrupting transgene. Mol. Cell. Neurosci. 6, 532–543 (1995).
Tu, P.-H. et al. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHlacZ transgenic mice. J. Neurosci. 17, 1064–1074 (1997).
Guo, L. et al. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified squamos epithelia and severe neurologic degeneration. Cell 81, 233–243 (1995).
Duchen, L. W. Dystonia musculorum: an inherited disease of the nervous system in the mouse. Adv. Neurol. 14, 353–365 (1976).
Kothary, R. et al. Atransgene containing lacZ inserted into the dystonia locus is expressed in neural tube. Nature 335, 435–437 (1988).
Campbell, R. M. & Peterson, A. C. An intrinsic neuronal defect operates in dystonia musculorum: a study of dt/dt ↔ +/+ chimeras. Neuron 9, 693–703 (1992).
Sotelo, C. & Guenet, J. F. Pathologic changes in the CNS of dystonia musculorum mutant mouse: an animal model for human spinocerebellar ataxia. Neuroscience 27, 403–424 (1988).
Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
Beckman, J. S., Carson, M., Smith, C. D. & Koppenol, W. H. ALS, SOD and peroxynitrite. Nature 364, 584 (1993).
Collard, J.-F., Cote, F. & Julien, J. P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375, 61–64 (1995).
Figlewicz, D. et al. Variant alleles of the neurofilament heavy gene associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 3, 1757–1761 (1994).
Vechio, J., Bruijn, L., Brown, R. & Cleveland, D. Sequence variants in human neurofilament proteins: absence of linkage ot familial amyotrophic lateral sclerosis. Ann. Neurol. 40, 603–610 (1996).
Acknowledgements
We gratefully acknowledge the excellent technical assistance of T. Crossfield, K.Galloway-Kay, I. Tretjakoff and P. Valera. We also thank the ‘Centre de Microscopie Electronique de l'Université d'Angers’ and the Department of Neuropathology, MNI, for assistance in electron microscopy and image analysis. We are particularly grateful to J. Snipes, MNI, for helpful discussions. This investigation was supported through grants from the MRC and MDAC to A.C.P. and from the AFM to J.E. Travel support was provided by an INSERM/FRSQ award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eyer, J., Cleveland, D., Wong, P. et al. Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature 391, 584–587 (1998). https://doi.org/10.1038/35378
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35378
This article is cited by
-
Autophagy lipidation machinery regulates axonal microtubule dynamics but is dispensable for survival of mammalian neurons
Nature Communications (2020)
-
The model of local axon homeostasis - explaining the role and regulation of microtubule bundles in axon maintenance and pathology
Neural Development (2019)
-
Review on intermediate filaments of the nervous system and their pathological alterations
Histochemistry and Cell Biology (2013)
-
Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration
Molecular Neurobiology (2008)
-
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
BMC Genomics (2007)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.